News Quantified

NCNA – nucana plc - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

Form 6-K NuCana plc For: Nov 25

Form 6-K NuCana plc For: Nov 12

Form SC 13G/A NuCana plc Filed by: BAILLIE GIFFORD & CO

Form 424B5 NuCana plc

Form 6-K NuCana plc For: Sep 30

Top News Gainers

8/20 Form 6-K NuCana plc For: Aug 20 37.5%

3/4 NuCana PLC (NASDAQ: NCNA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.75 price target on the stock. 13.3%

10/25 NuCana PLC (NASDAQ: NCNA) had its "buy" rating re-affirmed by analysts at Cowen Inc. 8.7%

1/16 Form SC 13G/A NuCana plc Filed by: Morningside Venture Investments Ltd 8.3%

11/15 NuCana PLC (NASDAQ: NCNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock, down previously from $20.00. 7.9%

1/27 NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer 7.6%

8/29 NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference 7.5%

6/27 Form 6-K NuCana plc For: Jun 27 6.0%

8/19 NuCana PLC (NASDAQ: NCNA) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.3%

11/26 NuCana to Participate in the Piper Jaffray 31st Annual Healthcare Conference 5.2%

Top News Decliners

3/10 Form 20-F NuCana plc For: Dec 31 -15.5%

5/30 NuCana to Present at the Jefferies 2019 Healthcare Conference -14.5%

3/5 NuCana PLC (NASDAQ: NCNA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.2%

1/21 NuCana PLC (NASDAQ: NCNA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -9.2%

12/27 Form 6-K NuCana plc For: Dec 27 -8.9%

6/26 NuCana PLC (NASDAQ: NCNA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%

2/25 NuCana to Present at the Cowen and Company 40th Annual Health Care Conference -7.2%

11/12 NuCana PLC (NASDAQ: NCNA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -6.9%

2/14 Form SC 13G/A NuCana plc Filed by: WOOD CHRISTOPHER B -5.7%

5/8 NuCana PLC (NASDAQ: NCNA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day